How does serum brain natriuretic peptide level change under nasal continuous positive airway pressure in obstructive sleep apnea-hypopnea syndrome?

References

• Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 15: 136–43.
   Google Scholar
• American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. 2014; Chicago, LI: American Academy of Sleep Medicine.
   Google Scholar
• Bradley TD, Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009; 373: 82–93.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, etal. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003; 348: 1233–41.
   PubMed Web of Science ®Google Scholar
• Boerrigter G, Costello-Boerrigter LC, Burnett JC Jr. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin. 2009; 5: 501–14.
   Google Scholar
• Hübner RH, El Mokhtari NE, Freitag S, Rausche T, Göder R, Tiroke A, etal. NT-proBNP is not elevated in patients with obstructive sleep apnea. Respir Med. 2008; 102: 134–42.
   Web of Science ®Google Scholar
• Maeder MT, Strobel W, Christ M, Todd J, Estis J, Wildi K, etal. Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem. 2015; 48: 340–6.
   Web of Science ®Google Scholar
• Ljunggren M, Lindahl B, Theorell-Haglöw J, Lindberg E. Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women. Sleep. 2012; 35: 1521–7.
   Web of Science ®Google Scholar
• Tasci S, Manka R, Scholtyssek S, Lentini S, Troatz C, Stoffel-Wagner B, etal. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol. 2006; 95: 23–30.
   PubMed Web of Science ®Google Scholar
• Riachy M, Juvelikian G, Sleilaty G, Bazarbachi T, Khayat G, Mouradides C. Validation of the Arabic version of the Epworth sleepiness scale: multicentre study. Rev Mal Respir. 2012; 29: 697–704.
   Web of Science ®Google Scholar
• Blacher J, Lelong H, Kretz S, Yannoutsos A, Kondo T, Safar M. [JNC 8 is released … but this is not the JNC 8! New US guidelines for the management of hypertension]. Presse Med. 2014; 43: 1048–55.
   Web of Science ®Google Scholar
• Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, etal. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012; 15: 597–619.
   Google Scholar
• Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, etal. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993; 147: 887–95.
   PubMed Web of Science ®Google Scholar
• Kita H, Ohi M, Chin K, Noguchi T, Otsuka N, Tsuboi T, etal. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res. 1998; 7: 199–207.
   PubMed Web of Science ®Google Scholar
• Kaditis AG, Alexopoulos EI, Hatzi F, Kostadima E, Kiaffas M, Zakynthinos E, etal. Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. Chest. 2006; 130: 1377–84.
   Web of Science ®Google Scholar
• Woodard GE, Rosado JA. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol. 2008; 268: 59–93.
   PubMed Web of Science ®Google Scholar
• Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol. 2011; 57: 119–27.
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995; 96: 1897–904.
   PubMed Web of Science ®Google Scholar
• Maeder MT, Ammann P, Rickli H, Schoch OD, Korte W, Hürny C, etal. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath. 2008; 12: 7–16.
   Web of Science ®Google Scholar
• Cifçi N, Uyar M, Elbek O, Süyür H, Ekinci E. Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath. 2010; 14: 241–4.
   Web of Science ®Google Scholar
• Zhao ZH, Liu ZH, Luo Q, Xiong CM, Ni XH, Zhang J, etal. Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea. Circ J. 2006; 70: 572–4.
   Web of Science ®Google Scholar
• Sharpey-Schafer EP. Hamilton WFDP. Effect of respiratory acts on the circulation. Handbook of physiology: a critical, comprehensive presentation of physiological knowledge and concepts. Section II: circulation. 1965; Washington, DC: American Physiological Society. 1875–86.
   Google Scholar
• Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, etal. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest. 2012; 141: 674–81.
   PubMed Web of Science ®Google Scholar
• Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046–53.
   PubMed Web of Science ®Google Scholar